Abbott India has informed that the meeting of the Board of Directors of the Company is scheduled on 07/08/2024 to consider and approve the Unaudited Financial Results of the Company for the first quarter ended on June 30, 2024. Further, in terms of Abbott India Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Insiders and in accordance with the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and further to the intimation dated June 26, 2024, the Trading Window of the Company remains closed from Monday, July 1, 2024 to Friday, August 9, 2024.
The above information is a part of company’s filings submitted to BSE.
